Peptides in Skincare: What Works, What Doesn't, and What to Look For
Peptides are the hottest ingredient in skincare right now. They're also the most confusing.
The word appears on serums, moisturizers, eye creams, supplements, and injectable vials. It's used to sell $25 drugstore products and $500 clinic treatments. It's on TikTok, in dermatologist recommendations, on Amazon bestseller lists, and in the ingredient decks of products at every price point imaginable.
And most of the time, nobody explains what the specific peptide in the product actually does, at what concentration, or whether there's evidence it works at that concentration in a topical formula.
"Contains peptides" has become the skincare equivalent of "contains ingredients." It sounds scientific. It tells you almost nothing.
So let's sort it out. Because there's real science in this category. There's also a staggering amount of hype. And the difference between the two comes down to a few questions nobody is teaching you to ask.
What a Peptide Actually Is (In 30 Seconds)
Amino acids are building blocks. Peptides are short chains of amino acids, typically 2 to 50 linked together. Proteins are longer chains, 50 and up.
Collagen is a protein. Elastin is a protein. Enzymes are proteins. Your skin is built on proteins.
The peptides in your skincare are short sequences designed to mimic fragments of those larger proteins. The idea is that these small fragments can "signal" your skin to produce more of the full protein, or "inhibit" enzymes that are breaking it down, or "carry" essential minerals to where they're needed.
That's it. That's what a peptide is. A short chain of amino acids designed to do a specific job. The rest of the conversation is about which specific chain, doing which specific job, backed by how much evidence, at what concentration in the bottle you're holding.
The Four Types of Topical Peptides (And What Each One Actually Does)
Not all peptides do the same thing. The category splits into four types based on mechanism. Think of them as four different employees with four different job descriptions.
The foreman: signal peptides.
Signal peptides are the ones that walk onto the job site and yell "build more."
When your skin detects certain short amino acid fragments, it interprets them as evidence that collagen or elastin is being broken down. The fragments are basically debris. And when your skin sees debris, it assumes something is falling apart and kicks the construction crew into gear.
Signal peptides exploit this. They mimic the debris. Your skin sees them, panics (productively), and starts building.
The best-studied example is Matrixyl (palmitoyl pentapeptide-4). Multiple published studies, including randomized trials, show it increases collagen production and measurably reduces wrinkles. If topical peptides have a valedictorian, it's Matrixyl.
Copper peptide (GHK-Cu) also belongs here. It's a naturally occurring tripeptide, meaning your body already makes it, though production declines with age. Clinical data shows it stimulates collagen, elastin, and the moisture-holding molecules in your skin. It's one of the few peptides where the body recognizes it as part of its own repair system rather than something foreign. That gives it a biological credibility that purely synthetic sequences don't always have.
Evidence level: moderate to good for Matrixyl and GHK-Cu. Weak to nonexistent for many of the branded "peptide complexes" with trademarked names and minimal published data.
The delivery driver: carrier peptides.
Carrier peptides don't build anything themselves. They deliver the materials someone else needs to build.
Specifically, they transport trace minerals, primarily copper, into the skin. Copper is essential for the enzymes that crosslink collagen fibers (making them stronger), support antioxidant defense, and drive wound healing. Without copper, those enzymes can't do their jobs.
GHK-Cu is the headline example again here. It wears two hats: it signals the construction crew to build more AND it carries the copper they need to do the work. It's the foreman who shows up with the lumber.
Evidence level: good for GHK-Cu specifically. The carrier peptide category is small. GHK-Cu is essentially the entire starting lineup.
The muscle relaxer: neurotransmitter inhibitor peptides.
You've seen these marketed as "Botox in a bottle." The pitch: a topical peptide that relaxes the facial muscles behind expression lines, smoothing crow's feet and forehead wrinkles without a needle.
Argireline (acetyl hexapeptide-3) is the most famous. The mechanism is real: it interferes with the chemical signal that tells your muscles to contract. Same basic idea as Botox, which blocks that signal at the injection site.
The difference? Botox is injected directly into the muscle. It arrives at full concentration exactly where it needs to be. Argireline is applied to the surface of your skin and has to cross an entire barrier, navigate through tissue, and somehow reach the nerve-muscle junction in a concentration high enough to do something.
It's the difference between handing someone a letter in person and mailing it to a country that may or may not have a functioning postal system. The letter exists. Whether it arrives is another question.
Studies do show modest wrinkle reduction with Argireline. Modest is the operative word. If Botox is a dimmer switch that takes a room from bright to dark, Argireline is someone squinting at the light and hoping it looks a little softer. The effect is real. The scale is not comparable. Anyone selling it as a needle-free Botox alternative is selling the dream, not the data.
Evidence level: moderate. It does something. Just not what the marketing implies.
The bodyguard: enzyme inhibitor peptides.
The first three types are all about building more. This one is about losing less.
Your skin is constantly being taken apart. Enzymes break down collagen. Enzymes break down elastin. Enzymes break down hyaluronic acid. That's normal. It's part of the turnover process. But after 50, the demolition crew is working overtime while the construction crew is short-staffed. The math stops working.
Enzyme inhibitor peptides slow the demolition.
The most practical example in this category, and the one we use, is polyglutamic acid (PGA), a glutamic acid polypeptide. PGA inhibits hyaluronidase, the enzyme that breaks down hyaluronic acid in your skin. This is the same enzyme dermatologists inject to dissolve HA-based lip filler, which tells you exactly how aggressively it degrades hyaluronic acid. A US patent (8916141) was granted specifically for PGA's use as a hyaluronidase inhibitor, and a human clinical study with 50 women confirmed it maintained skin elasticity by inhibiting the enzyme's activity.
Other enzyme inhibitor peptides go after the enzymes that chew through collagen and elastin. That subcategory is newer, mostly still in lab-stage testing. Promising idea. Early data.
Think of it this way: the other three peptide types are trying to build a sandcastle faster. Enzyme inhibitors are trying to slow the tide. Both matter. But if the tide is eating your castle faster than you can build it, slowing the tide might be the smarter move.
Evidence level: strong for PGA's hyaluronidase inhibition. Emerging for the broader category.
The Penetration Problem (The Question Every Peptide Brand Hopes You Don't Ask)
Here's the uncomfortable truth sitting underneath the entire topical peptide category.
Peptides are molecules. They have size. To affect living skin cells, they need to cross the stratum corneum (the outermost layer of dead cells) and reach the epidermis or upper dermis where those living cells reside.
The stratum corneum is a lipid barrier. It was designed, over millions of years of evolution, to keep things out. It does this job well. Large, hydrophilic (water-loving) molecules don't pass through easily. And most peptides, in their native form, are large and hydrophilic.
This is the fundamental challenge of topical peptide delivery.
The industry's primary solution is lipidation: attaching a fatty acid chain (usually palmitic acid) to the peptide to make it more lipophilic (fat-loving). This is why you see "palmitoyl" in front of so many peptide names. Palmitoyl pentapeptide. Palmitoyl tripeptide. Palmitoyl tetrapeptide. The fatty acid tail helps the molecule slip through the lipid barrier more easily.
Does lipidation solve the problem? It improves penetration. It doesn't guarantee that a therapeutic concentration reaches the target cells. The gap between "some molecules cross the barrier" and "enough molecules reach the target to produce a biological effect" is real, and it's the gap the industry would prefer you not think about.
The published studies on peptides like Matrixyl were conducted using specific concentrations in specific vehicles (the formula surrounding the peptide matters for delivery). The product you buy at retail may use a different concentration in a different vehicle. Whether the study's results translate to the product on your shelf is an open question for most peptide products.
None of this means topical peptides don't work. It means the delivery challenge is real, the evidence for specific formulations doesn't automatically transfer to every product containing the same ingredient name, and the consumer should understand that "contains peptide X" and "delivers peptide X to your skin cells at a meaningful concentration" are two different statements.
The Concentration Problem (The Other Question They'd Rather You Didn't Ask)
Most skincare brands don't disclose the concentration of their peptides.
"Contains Matrixyl" tells you the ingredient is in the formula. It doesn't tell you how much. A peptide at 4% in a study that showed results and a peptide at 0.001% in a product that needs to hit a $30 price point are the same ingredient name on the label. They are not the same product.
Peptides are expensive raw materials. The more you use, the higher the cost of goods. For brands working to retail margins, the incentive is to include the minimum amount that allows the ingredient to appear on the label, not the amount that matches the published research.
Without concentration disclosure, you have no way to evaluate whether the peptide in your serum is at a biologically relevant level or whether it's a label decoration, there for marketing rather than for your skin.
The brands with the strongest peptide science (typically medical-grade or professional lines) tend to be more transparent about concentrations and formulation details. The brands riding the peptide trend with the least substance tend to be the least transparent. That pattern is worth noticing.
What to look for: Brands that disclose peptide concentrations or reference specific studies using their formulation. Products that name specific peptides rather than hiding behind proprietary "peptide complexes." And price points that are consistent with using expensive ingredients at meaningful levels. A $15 serum claiming five different peptides is almost certainly using all five at trace amounts.
Injectable Peptides: A Different World Entirely
This section is brief because injectable peptides are a medical conversation, not a skincare conversation. But the category is so prominent right now that ignoring it would leave a gap.
Injectable peptides (BPC-157, TB-500, GHK-Cu injections, CJC-1295, ipamorelin, and others) bypass the skin barrier entirely. They're delivered directly into tissue. This solves the penetration problem but creates entirely different concerns: sterility, dosing, purity, source verification, and regulation.
The regulatory landscape in 2026 is fluid. The FDA placed 19 peptides on its Category 2 restricted list in 2023, effectively banning compounding pharmacies from preparing them. In early 2026, HHS signaled that most would be reclassified to Category 1, but as of this writing, the formal review (scheduled for July 2026) hasn't concluded. The result has been a grey market of "research use only" peptides sold online with no guarantee of purity, concentration, or sterility.
The evidence base for most injectable peptides is primarily preclinical. BPC-157, for example, has over 100 animal studies but only a handful of small human trials, none of which would meet the standard for drug approval. The human data is thin. The animal data is promising. The gap between the two is where the risk lives.
If injectable peptides interest you, work with a licensed physician who can navigate the regulatory situation, verify sourcing, and monitor your response. An Instagram vendor selling "research chemicals" is not a medical provider, regardless of the testimonials.
What the Evidence Actually Supports (The Honest Scorecard)
Strong evidence: Matrixyl (palmitoyl pentapeptide-4) for collagen stimulation and wrinkle reduction. Multiple published studies including randomized controlled trials. GHK-Cu (topical) for wound healing, collagen support, and skin repair. PGA for hyaluronidase inhibition, with a granted US patent and a human clinical study.
Moderate evidence: Argireline (acetyl hexapeptide-3) for expression line reduction. Real effect, modest magnitude, published studies but not pharmaceutical-grade RCTs. Effect should not be compared to injectable botulinum toxin.
Emerging evidence: MMP-inhibitor peptides, newer signal peptide analogs, and some carrier peptide variants. In-vitro and ex-vivo data. Promising mechanisms. Not enough human clinical evidence to make definitive claims.
Insufficient evidence: The majority of proprietary "peptide complexes" in consumer products. Trademarked names, minimal published data, undisclosed concentrations, no independent replication. The ingredient is present. The evidence is not.
Where Peptides Fit in a Skincare Routine (And What They Can't Replace)
Peptides are a legitimate category of cosmetic actives. The best-studied ones can support collagen production, promote repair, protect hyaluronic acid, and modestly reduce wrinkles when delivered at appropriate concentrations in well-designed formulations.
But they're not a foundation. They're an addition.
No peptide serum replaces barrier repair. No peptide replaces hydration. No peptide replaces SPF. A peptide applied to a compromised barrier is a signal sent to skin that can't hear it. The barrier has to be functional for the communication to work.
This is why our approach starts with the foundation: ceramides, cholesterol, and fatty acids to rebuild the barrier. Glycerin and hyaluronic acid to hydrate. And PGA, our enzyme inhibitor peptide, to protect the HA from being destroyed by hyaluronidase. The peptide sits inside a system designed to make it effective, not on top of skin that can't receive it.
If you want to add a signal peptide or a copper peptide on top of that foundation, the evidence supports certain options, and this blog told you which ones. But the foundation comes first. Always.
Peptides Are Real Science in a Hype Economy
Peptides aren't fraud. A handful of specific molecules have genuine, published evidence. A larger group has promising early data. And the majority have very little beyond a name on a label and a marketing department that knows the word "peptide" sells.
The word "peptide" on a product tells you almost nothing. The specific peptide, at a disclosed concentration, in a formula designed for penetration, backed by published data, tells you everything.
Before you buy, ask three questions: Which peptide? How much? Where's the evidence? If the brand can't answer all three, the product is selling you the word, not the science.
Frequently Asked Questions
What are peptides in skincare? Peptides are short chains of amino acids (typically 2 to 50) designed to interact with skin cells. In skincare, they fall into four categories: signal peptides (stimulate collagen production), carrier peptides (deliver trace minerals like copper), neurotransmitter inhibitors (relax expression muscles), and enzyme inhibitors (block enzymes that break down collagen, elastin, or hyaluronic acid). Their effectiveness depends on the specific peptide, its concentration, and whether the formulation delivers it past the skin barrier.
Do peptide serums actually work? Some do, at the right concentration in the right formulation. Matrixyl (palmitoyl pentapeptide-4) and GHK-Cu have the strongest topical evidence. Argireline has moderate evidence for modest wrinkle reduction. Polyglutamic acid has strong evidence for hyaluronidase inhibition. Many other peptide products use undisclosed concentrations of less-studied peptides, making it impossible to evaluate their efficacy from the label alone.
What's the best peptide for wrinkles? For collagen-driven wrinkle improvement, Matrixyl has the strongest published evidence. For expression lines specifically, Argireline shows modest results (though far less than injectable Botox). For overall skin quality, GHK-Cu supports repair and collagen synthesis. The "best" peptide depends on the type of wrinkle and the quality of the formulation.
Are injectable peptides safe? Injectable peptides bypass the skin barrier, which solves the delivery problem but introduces concerns about sterility, purity, and dosing. Most injectable peptides (BPC-157, TB-500, etc.) are not FDA-approved for human use. The regulatory situation is evolving in 2026. If you're considering injectables, work with a licensed physician, not an online vendor.
Can peptides replace retinol? They serve different functions. Retinol accelerates cell turnover and stimulates collagen through a well-studied mechanism. Signal peptides stimulate collagen through a different pathway (mimicking breakdown signals). They can complement each other. Neither fully replaces the other. For women over 50 with compromised barriers, peptides may be better tolerated than retinol, since they don't force turnover on depleted skin.
How do I know if a peptide product has enough active ingredient? Look for brands that disclose concentration, name specific peptides rather than proprietary blends, and reference published studies. If the label says "peptide complex" without naming the peptides or their concentrations, you're buying marketing confidence, not scientific transparency.
Sources
Nukaly, H.Y., et al. "Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials." Frontiers in Medicine. 2026. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1618306/full
Errante, F., et al. "Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence." Cosmetics. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11762834/
Zhang, Y., et al. "Role of peptide-cell surface interactions in cosmetic peptide application." Frontiers in Pharmacology. 2023. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1267765/full
US Patent 8916141. "Hyaluronidase Inhibitor Containing Poly-Gamma-Glutamic Acid as an Effective Component." BioLeaders Corporation. https://patents.google.com/patent/US20080247986A1/en
Pickart, L., et al. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." BioMed Research International. 2015. https://pubmed.ncbi.nlm.nih.gov/25802849/